|
|
 |
|
Viewing report
|
|
|
|
Commercial Insight: Osteoarthritis and Rheumatoid Arthritis - New Growth In A Mature Market
Datamonitor, July 2003, Pages: 129
Introduction
This analysis focuses on the changing landscape of the commercial environment in the global arthritis market and investigates key strategies required to succeed. Analysis of company portfolio strategies and product positioning provides in-depth knowledge of how specific company strategies result in varying levels of commercial returns.
Scope
- Detailed case studies featuring company portfolio, product development and launch strategies of leading global players in arthritis
- Global sales data for the major classes used in treating arthritis - Nsaids, Dmards, HA viscosupplements and steroids
- Event-based forecasts to 2011 for the top selling drugs in each class
- Swot analyses of key arthritis drugs, along with 12-month event screens - providing detailed knowledge of events specific to each product
Report Highlights
Despite facing adversity in the past year, including continued negative publicity surrounding the cardiovascular side effect profile of Vioxx and the delayed launch of Arcoxia, Merck will remain a strong competitor for Pfizer/Pharmacia in the future and the Cox-ii inhibitor class will continue to flourish through 2011.
The alleviation of Enbrel’s supply shortage through the new manufacturing facility approved in early 2003 will enable Amgen to regain a significant portion of sales lost to J&J’s Remicade although Humira is presenting formidable competition for both drugs.
Reasons to Purchase
- Target current and future growth areas through identification of the strongest product lifecycle and pricing strategies
- Learn from case studies analyzing details of the most successful drug launches in the arthritis market
- Plan future product positioning through utilization of event-based forecasts for all major arthritis drugs
Customers who bought this item also bought
Rheumatoid Arthritis Drug Discoveries: What The Future Holds
Br Malls Participacoes Sa
Br. Holdings Corporation
Pipeline Insight: Rheumatoid Arthritis and Osteoarthritis - Striving for innovation among me-toos
Osteoarthritis and Rheumatoid Arthritis: Opinion Leader Forum - Expert's Views and Perspectives on Diagnosis, Treatment, Product Performance and Closing the Need Gap
Drugs of Tomorrow 2002: Arthritis
Market Dynamics: Arthritis - The Ongoing Battle for Supremacy
The Rheumatoid Arthritis Market - Competitive Landscape and Clinical Stage Analysis
Drugs of Tomorrow 2000: Arthritis - Developments For a Competitive Market
The World Market for Butadiene Rubber (BR): A 2009 Global Trade Perspective
The 2009 Import and Export Market for Butadiene Rubber (BR) in Iran
The 2009 Import and Export Market for Butadiene Rubber (BR) in Colombia
|
|
|
|
